Olotela Eye Drops 0.2% (Olopatadine Hydrochloride) (Single Use)

Adult eye dose

1 drop once daily.

This medication should not be used by patients who are allergic to the active ingredient or any of its components. When using this medication, neurological symptoms such as headache, dysgeusia, and dizziness may rarely occur. In terms of eye-related symptoms, keratitis, eye pain, dryness, itching, and eye congestion may occur, and rarely, symptoms such as glare or blurred vision may also be experienced. Nasal dryness or rhinitis may rarely develop, and dry mouth has also been reported. Caution should be used as there is a possibility of contact dermatitis. You may feel fatigued after using this medication. Additionally, symptoms similar to cold or pharyngitis may occur in some patients, with reports of malaise, low back pain, flu-like symptoms, frequent coughing, and nausea. This medication contains phosphate, and caution is required as corneal calcification may very rarely occur in patients with severe corneal damage. Contact lens wearers should wait at least 15 minutes after using this medication before wearing lenses, and it should not be used to relieve lens-related irritation. This medication contains benzalkonium chloride as a preservative, which may cause eye irritation and discoloration of soft contact lenses, so caution is advised. There may be temporary blurred vision after use, so one should wait until vision returns to normal before driving or operating machinery. During pregnancy, the effects on the fetus are not fully known, so it should only be used if deemed necessary by a physician, and caution is also advised during breastfeeding as it may affect the infant. Children over 3 years of age can use it, and it is also safe for the elderly. Excessive use requires appropriate observation and management. This medication should only be used for direct application to the eyes and should not be administered by mouth or intravenously. Care should be taken not to let the tip of the container touch the eye or skin to avoid contamination, and the cap should be tightly closed after use. If used with other eye drops, at least a 5-minute interval should be maintained, and ointments should be used last. If the medication is in a single-use container, it should only be used once, and when first using it, 1-2 drops should be discarded to remove foreign substances from the container. During storage, ensure the cap is tightly closed when not in use to keep it clean. This medication is known to have a low carcinogenic or mutagenic risk and is not believed to significantly affect reproductive ability even with long-term use.

Mild side effects

• Headache
• dysgeusia
• dizziness
• punctate keratitis
• keratitis
• eye pain
• dry eyes
• eyelid swelling
• itching of the eyes
• eye discharge

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. The appropriate storage temperature is a cool place between 2 to 25 degrees Celsius.

Appearance

An eye drop solution that is colorless to pale yellow in a clear plastic container.

Package unit

9 milliliters/box [0.3 mL x 30 vials]